American Regent announced the re-introduction of Aminocaproic Acid Injection, USP, a therapeutically equivalent generic alternative to Amicar®.
Aminocaproic Acid Injection, USP is useful in enhancing hemostasis when fibrinolysis contributes to bleeding, "With the re-introduction of Aminocaproic Acid Injection, USP, we continue to demonstrate our commitment to ensuring both patients and providers have access to treatment options that may not be readily available due to drug shortages," said Ken Keller, President and CEO of American Regent, Inc.
In life-threatening situations, fresh whole blood transfusions, fibrinogen infusions, and other emergency measures may be required. Aminocaproic acid should not be used when there is evidence of an active intravascular clotting process.
Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special offers
from American Pharmaceutical Review – all delivered right to your inbox! Sign up now!